Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2022 Apr 19. pii: 694506. doi: 10.1158/1055-9965.EPI-21-1003
    Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region.
    Jordahl KM1,  Shcherbina A2,  Kim AE3,  Su YR4,  Lin Y5,  Wang J6,  Qu C7,  Albanes D8,  Arndt V9,  Baurley JW10,  Berndt SI11,  Bien SA12,  Bishop DT13,  Bouras E14,  Brenner H15,  Buchanan DD16,  Budiarto A17,  Campbell PT18,  Carreras-Torres R19,  Casey G20,  Cenggoro TW21,  Chan AT22,  Conti DV23,  Dampier CH24,  Devall MA25,  Díez-Obrero V26,  Dimou N27,  Drew DA28,  Figueiredo JC29,  Gallinger S30,  Giles GG31,  Gruber SB32,  Gsur A33,  Gunter MJ34,  Hampel H35,  Harlid S36,  Harrison TA37,  Hidaka A38,  Hoffmeister M39,  Huyghe JR40,  Jenkins MA41,  Joshi AD42,  Keku TO43,  Larsson SC44,  Le Marchand L45,  Lewinger JP46,  Li L47,  Mahesworo B48,  Moreno V49,  Morrison JL50,  Murphy N51,  Nan H52,  Nassir R53,  Newcomb PA54,  Obón-Santacana M55,  Ogino S56,  Ose J57,  Pai RK58,  Palmer JR59,  Papadimitriou N60,  Pardamean B61,  Peoples AR62,  Pharoah PDP63,  Platz EA64,  Potter JD65,  Prentice RL66,  Rennert G67,  Ruiz-Narvaez E68,  Sakoda LC69,  Scacheri PC70,  Schmit SL71,  Schoen RE72,  Slattery ML73,  Stern MC74,  Tangen CM75,  Thibodeau SN76,  Thomas DC77,  Tian Y78,  Tsilidis KK79,  Ulrich CM80,  van Duijnhoven FJB81,  Van Guelpen B82,  Visvanathan K83,  Vodicka P84,  White E85,  Wolk A86,  Woods MO87,  Wu AH88,  Zemlianskaia N89,  Chang-Claude J90,  Gauderman WJ91,  Hsu L92,  Kundaje A93,  Peters U94
    Author information
    1Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
    2Department of Genetics, Stanford University, Stanford, California.
    3Division of Biostatistics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
    4Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    5Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    6Division of Biostatistics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
    7Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    8Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    9Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    10Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia.
    11Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    12Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    13Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
    14Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
    15Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    16Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
    17Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia.
    18Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.
    19Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
    20Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia.
    21Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia.
    22Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
    23Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
    24Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia.
    25Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia.
    26Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
    27Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
    28Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
    29Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
    30Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
    31Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
    32Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
    33Institute of Cancer Research, Department of Medicine I, Medical University Vienna, Vienna, Austria.
    34Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.
    35Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
    36Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden.
    37Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    38Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    39Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    40Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    41Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
    42Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
    43Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina.
    44Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
    45University of Hawaii Cancer Center, Honolulu, Hawaii.
    46Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
    47Department of Family Medicine, University of Virginia, Charlottesville, Virginia.
    48Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia.
    49Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
    50Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
    51Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.
    52Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indianapolis, Indiana.
    53Department of Pathology, School of Medicine, Umm Al-Qura'a University, Saudi Arabia.
    54Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
    55Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Avda Gran Via Barcelona 199-203, 08908L'Hospitalet de Llobregat, Barcelona, Spain.
    56Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
    57Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
    58Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona.
    59Slone Epidemiology Center at Boston University, Boston, Massachusetts.
    60Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
    61Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia.
    62Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
    63Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    64Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
    65Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    66Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    67Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.
    68Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan.
    69Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    70Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio.
    71Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
    72Department of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
    73Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
    74Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
    75SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    76Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
    77Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
    78Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    79Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
    80Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
    81Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
    82Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden.
    83Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
    84Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
    85Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
    86Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
    87Memorial University of Newfoundland, Discipline of Genetics, St. John's, Canada.
    88Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
    89Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
    90Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    91Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
    92Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
    93Department of Genetics, Stanford University, Stanford, California.
    94Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
    Abstract

    BACKGROUND: Currently known associations between common genetic variants and colorectal cancer explain less than half of its heritability of 25%. As alcohol consumption has a J-shape association with colorectal cancer risk, nondrinking and heavy drinking are both risk factors for colorectal cancer.

    METHODS: Individual-level data was pooled from the Colon Cancer Family Registry, Colorectal Transdisciplinary Study, and Genetics and Epidemiology of Colorectal Cancer Consortium to compare nondrinkers (≤1 g/day) and heavy drinkers (>28 g/day) with light-to-moderate drinkers (1-28 g/day) in GxE analyses. To improve power, we implemented joint 2df and 3df tests and a novel two-step method that modifies the weighted hypothesis testing framework. We prioritized putative causal variants by predicting allelic effects using support vector machine models.

    RESULTS: For nondrinking as compared with light-to-moderate drinking, the hybrid two-step approach identified 13 significant SNPs with pairwise r2 > 0.9 in the 10q24.2/COX15 region. When stratified by alcohol intake, the A allele of lead SNP rs2300985 has a dose-response increase in risk of colorectal cancer as compared with the G allele in light-to-moderate drinkers [OR for GA genotype = 1.11; 95% confidence interval (CI), 1.06-1.17; OR for AA genotype = 1.22; 95% CI, 1.14-1.31], but not in nondrinkers or heavy drinkers. Among the correlated candidate SNPs in the 10q24.2/COX15 region, rs1318920 was predicted to disrupt an HNF4 transcription factor binding motif.

    CONCLUSIONS: Our study suggests that the association with colorectal cancer in 10q24.2/COX15 observed in genome-wide association study is strongest in nondrinkers. We also identified rs1318920 as the putative causal regulatory variant for the region.

    IMPACT: The study identifies multifaceted evidence of a possible functional effect for rs1318920.


    ©2022 American Association for Cancer Research.

    Publikations ID: 35438744
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt